|
Media Releases |
Financial Reports |
Presen-tations |
|
10/05/2007
|
|
|
|
| |
Basel, 05.10.2007 - Lonza announces a worldwide price increase of 15 - 20 % for Niacin and Niacinamide feed grade due to continued increases of raw materials, energy and transportation costs.
The price increase will come into effect on 1 January 2008.
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2006, Lonza had sales of CHF 2.91 billion. Further information can be found at www.lonza.com.
For further information:
Business Unit Nutrition
Matthias Schaub
Tel +41 61 316 8552
Fax +41 61 316 9552
matthias.schaub@lonza.com
Media Relations Lonza
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9798
dominik.werner@lonza.com
|
|
|
